HEADER OXIDOREDUCTASE 05-APR-07 2PFH TITLE COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND TITLE 2 COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF TITLE 3 FIDARESTAT IN SOAKING SOLUTION IS LESS THAN CONCENTRATION OF IDD594. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AR, ALDEHYDE REDUCTASE; COMPND 5 EC: 1.1.1.21; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE, NADP, IDD594, FIDARESTAT EXPDTA X-RAY DIFFRACTION AUTHOR T.PETROVA,I.HAZEMANN,A.COUSIDO,A.MITSCHLER,S.GINELL,A.JOACHIMIAK, AUTHOR 2 A.PODJARNY REVDAT 6 30-AUG-23 2PFH 1 REMARK REVDAT 5 17-OCT-12 2PFH 1 JRNL REVDAT 4 25-JUL-12 2PFH 1 JRNL REVDAT 3 11-JUL-12 2PFH 1 JRNL VERSN REVDAT 2 24-FEB-09 2PFH 1 VERSN REVDAT 1 17-APR-07 2PFH 0 JRNL AUTH A.COUSIDO-SIAH,T.PETROVA,I.HAZEMANN,A.MITSCHLER,F.X.RUIZ, JRNL AUTH 2 E.HOWARD,S.GINELL,C.ATMANENE,A.VAN DORSSELAER, JRNL AUTH 3 S.SANGLIER-CIANFERANI,A.JOACHIMIAK,A.PODJARNY JRNL TITL CRYSTAL PACKING MODIFIES LIGAND BINDING AFFINITY: THE CASE JRNL TITL 2 OF ALDOSE REDUCTASE. JRNL REF PROTEINS V. 80 2552 2012 JRNL REFN ISSN 0887-3585 JRNL PMID 22752989 JRNL DOI 10.1002/PROT.24136 REMARK 2 REMARK 2 RESOLUTION. 0.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.082 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.082 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.095 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 12685 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 253545 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.077 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.077 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.090 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 11616 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 232386 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2492 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 119 REMARK 3 SOLVENT ATOMS : 656 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3009.8 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2441.2 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 406 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 35222 REMARK 3 NUMBER OF RESTRAINTS : 51858 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.026 REMARK 3 ANGLE DISTANCES (A) : 0.055 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.121 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.113 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.150 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.006 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.030 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.082 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PFH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042319. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.65255 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 UTILIZING A SI-111 AND SAGITAL REMARK 200 HORIZONTAL FOCUSING REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 240860 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.14300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1US0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MICRO-SEEDING, PH 5.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.27650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 314 REMARK 465 PHE A 315 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 119 CE NZ REMARK 470 LYS A 307 CE NZ REMARK 470 GLU A 313 CA C O CB CG CD OE1 REMARK 470 GLU A 313 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 126 CD OE1 OE2 REMARK 480 TRP A 295 CE3 CZ2 CZ3 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 29 CD GLU A 29 OE1 -0.077 REMARK 500 ARG A 293 CB ARG A 293 CG -0.200 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 3 NH1 - CZ - NH2 ANGL. DEV. = 7.3 DEGREES REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -8.0 DEGREES REMARK 500 ARG A 63 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 GLU A 64 N - CA - CB ANGL. DEV. = -13.8 DEGREES REMARK 500 TYR A 82 CB - CG - CD1 ANGL. DEV. = 3.9 DEGREES REMARK 500 GLU A 84 OE1 - CD - OE2 ANGL. DEV. = 10.1 DEGREES REMARK 500 ASP A 134 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 134 CB - CG - OD2 ANGL. DEV. = -7.6 DEGREES REMARK 500 LYS A 194 CA - CB - CG ANGL. DEV. = 13.4 DEGREES REMARK 500 ASP A 216 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ARG A 217 N - CA - CB ANGL. DEV. = 11.3 DEGREES REMARK 500 ARG A 217 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG A 217 NE - CZ - NH1 ANGL. DEV. = -4.0 DEGREES REMARK 500 ARG A 217 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 GLU A 223 CA - C - N ANGL. DEV. = 13.8 DEGREES REMARK 500 ASP A 224 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG A 232 NE - CZ - NH1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 268 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ASN A 272 N - CA - CB ANGL. DEV. = 15.4 DEGREES REMARK 500 PHE A 276 CB - CG - CD2 ANGL. DEV. = -4.7 DEGREES REMARK 500 PHE A 276 CB - CG - CD1 ANGL. DEV. = 7.0 DEGREES REMARK 500 ARG A 293 NE - CZ - NH1 ANGL. DEV. = -5.3 DEGREES REMARK 500 ARG A 293 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 CYS A 298 CB - CA - C ANGL. DEV. = 10.8 DEGREES REMARK 500 CYS A 298 O - C - N ANGL. DEV. = -15.3 DEGREES REMARK 500 THR A 304 C - N - CA ANGL. DEV. = -15.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 21 -3.16 78.12 REMARK 500 LEU A 190 81.32 -151.58 REMARK 500 ASP A 224 153.96 -37.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 209 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 318 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LDT A 320 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FID A 321 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 450 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1USO RELATED DB: PDB REMARK 900 RELATED ID: 1PWD RELATED DB: PDB REMARK 900 RELATED ID: 2I16 RELATED DB: PDB REMARK 900 RELATED ID: 2I17 RELATED DB: PDB REMARK 900 RELATED ID: 2ACR RELATED DB: PDB REMARK 900 RELATED ID: 2ACQ RELATED DB: PDB REMARK 900 RELATED ID: 2PEV RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE IS A LEU -> ILE SEQUENCE CONFLICT AT RESIDUE 5 IN THE REMARK 999 UNIPORT DATABASE. DBREF 2PFH A 0 315 UNP P15121 ALDR_HUMAN 1 316 SEQADV 2PFH ILE A 4 UNP P15121 LEU 5 SEE REMARK 999 SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE HET CL A2000 1 HET NDP A 318 48 HET LDT A 320 24 HET FID A 321 20 HET CIT A 400 13 HET CIT A 450 13 HETNAM CL CHLORIDE ION HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM LDT IDD594 HETNAM FID (2S,4S)-2-AMINOFORMYL-6-FLUORO-SPIRO[CHROMAN-4,4'- HETNAM 2 FID IMIDAZOLIDINE]-2',5'-DIONE HETNAM CIT CITRIC ACID HETSYN LDT [2-(4-BROMO-2-FLUORO-BENZYLTHIOCARBAMOYL)-5-FLUORO- HETSYN 2 LDT PHENOXY]-ACETIC ACID HETSYN FID FIDARESTAT FORMUL 2 CL CL 1- FORMUL 3 NDP C21 H30 N7 O17 P3 FORMUL 4 LDT C16 H12 BR F2 N O3 S FORMUL 5 FID C12 H10 F N3 O4 FORMUL 6 CIT 2(C6 H8 O7) FORMUL 8 HOH *656(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 GLU A 84 GLY A 86 5 3 HELIX 7 7 LEU A 87 LYS A 100 1 14 HELIX 8 8 ASN A 136 GLU A 150 1 15 HELIX 9 9 ASN A 162 ASN A 171 1 10 HELIX 10 10 GLN A 192 LYS A 202 1 11 HELIX 11 11 SER A 226 GLU A 229 5 4 HELIX 12 12 ASP A 230 ASN A 241 1 12 HELIX 13 13 THR A 243 ARG A 255 1 13 HELIX 14 14 THR A 265 LYS A 274 1 10 HELIX 15 15 SER A 281 SER A 290 1 10 HELIX 16 16 LEU A 300 THR A 304 5 5 SHEET 1 A 2 ARG A 3 LEU A 5 0 SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 B 8 LEU A 17 GLY A 18 0 SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109 SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 6 ALA A 45 HIS A 46 VAL A 47 LYS A 77 SITE 2 AC1 6 TRP A 79 HIS A 110 SITE 1 AC2 38 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC2 38 ASP A 43 TYR A 48 LYS A 77 HIS A 110 SITE 3 AC2 38 SER A 159 ASN A 160 GLN A 183 TYR A 209 SITE 4 AC2 38 SER A 210 PRO A 211 LEU A 212 GLY A 213 SITE 5 AC2 38 SER A 214 PRO A 215 ASP A 216 ALA A 245 SITE 6 AC2 38 ILE A 260 PRO A 261 LYS A 262 SER A 263 SITE 7 AC2 38 VAL A 264 THR A 265 ARG A 268 GLU A 271 SITE 8 AC2 38 ASN A 272 LDT A 320 FID A 321 HOH A3121 SITE 9 AC2 38 HOH A3151 HOH A3152 HOH A3185 HOH A3424 SITE 10 AC2 38 HOH A3541 HOH A3543 SITE 1 AC3 11 TRP A 20 VAL A 47 TYR A 48 HIS A 110 SITE 2 AC3 11 TRP A 111 THR A 113 CYS A 298 ALA A 299 SITE 3 AC3 11 LEU A 300 NDP A 318 HOH A3681 SITE 1 AC4 14 TRP A 20 VAL A 47 TYR A 48 TRP A 79 SITE 2 AC4 14 HIS A 110 TRP A 111 TRP A 219 CYS A 298 SITE 3 AC4 14 ALA A 299 LEU A 300 NDP A 318 HOH A3181 SITE 4 AC4 14 HOH A3679 HOH A3681 SITE 1 AC5 15 ASN A 162 HIS A 163 LYS A 194 LEU A 195 SITE 2 AC5 15 HOH A3001 HOH A3002 HOH A3017 HOH A3018 SITE 3 AC5 15 HOH A3115 HOH A3117 HOH A3277 HOH A3582 SITE 4 AC5 15 HOH A3625 HOH A3652 HOH A3682 SITE 1 AC6 20 GLN A 49 ASN A 50 GLU A 51 ASN A 52 SITE 2 AC6 20 GLU A 53 LYS A 94 ASP A 98 HOH A3004 SITE 3 AC6 20 HOH A3005 HOH A3006 HOH A3007 HOH A3010 SITE 4 AC6 20 HOH A3032 HOH A3041 HOH A3530 HOH A3531 SITE 5 AC6 20 HOH A3591 HOH A3633 HOH A3684 HOH A3685 CRYST1 49.147 66.553 47.238 90.00 92.31 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020347 0.000000 0.000821 0.00000 SCALE2 0.000000 0.015026 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021187 0.00000